Hannie Sietsma

3.9k total citations
22 papers, 1.0k citations indexed

About

Hannie Sietsma is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hannie Sietsma has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hannie Sietsma's work include Sphingolipid Metabolism and Signaling (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Lipid Membrane Structure and Behavior (5 papers). Hannie Sietsma is often cited by papers focused on Sphingolipid Metabolism and Signaling (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Lipid Membrane Structure and Behavior (5 papers). Hannie Sietsma collaborates with scholars based in Netherlands, United States and France. Hannie Sietsma's co-authors include Jan Kok, Bart‐Jan Kroesen, Robert Jan Veldman, Benjamin J. Pettus, Yusuf A. Hannun, Karin Klappe, Willem A. Kamps, Jan Willem Kok, John W. J. Hinrichs and Chiara Luberto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The FASEB Journal.

In The Last Decade

Hannie Sietsma

22 papers receiving 1.0k citations

Peers

Countries citing papers authored by Hannie Sietsma

Since Specialization

Citations

This map shows the geographic impact of Hannie Sietsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannie Sietsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannie Sietsma more than expected).

Fields of papers citing papers by Hannie Sietsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannie Sietsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannie Sietsma. The network helps show where Hannie Sietsma may publish in the future.

Co-authorship network of co-authors of Hannie Sietsma

This figure shows the co-authorship network connecting the top 25 collaborators of Hannie Sietsma. A scholar is included among the top collaborators of Hannie Sietsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannie Sietsma. Hannie Sietsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertension 2015 ·The Journal of Heart and Lung Transplantation ·Diederik E. van der Feen, Michael G. Dickinson, Beatrijs Bartelds, (unknown), Hannie Sietsma, Marilyne Lévy, Rolf M.F. Berger	26
2	A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension 2014 ·Cardiovascular Research ·Michael G. Dickinson, Piotr S. Kowalski, Beatrijs Bartelds, (unknown), (unknown), Hannie Sietsma, Grietje Molema, Jan A. A. M. Kamps, Rolf M.F. Berger	35
3	Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma 2012 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Erik Thunnissen, (unknown), Daniëlle A.M. Heideman, Katrien Grünberg, Dirk J. Kuik, (unknown), (unknown), (unknown), Cees A. Seldenrijk, Hannie Sietsma, Egbert F. Smit, Robert‐Jan van Suylen, Jan H. von der Thüsen, Bart Vrugt, Anne Wiersma, Birgit I. Lissenberg‐Witte, Michael den Bakker	24
4	Egr-1 Expression During Neointimal Development in Flow-Associated Pulmonary Hypertension 2011 ·American Journal Of Pathology ·Michael G. Dickinson, Beatrijs Bartelds, Grietje Molema, Marinus A.J. Borgdorff, (unknown), Janny Takens, (unknown), (unknown), Hannie Sietsma, Rolf M.F. Berger	32
5	Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: The NVALT-4 Study 2011 ·Journal of Clinical Oncology ·Harry J.M. Groen, Hannie Sietsma, Andrew Vincent, Monique Hochstenbag, John W.G. van Putten, Anke van den Berg, Otilia Dalesio, Bonne Biesma, Hans J.M. Smit, A. Termeer, T. Jeroen N. Hiltermann, Ben E.E.M. van den Borne, Franz M.N.H. Schramel	86
6	A chronic obstructive pulmonary disease related signature in squamous cell lung cancer 2010 ·Lung Cancer ·Mirjam C. Boelens, Adam M Gustafson, Dirkje S. Postma, Klaas Kok, Gerben van der Vries, Pieter van der Vlies, Avrum Spira, Marc E. Lenburg, Marie Geerlings, Hannie Sietsma, Wim Timens, Anke van den Berg, Harry J.M. Groen	24
7	Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis 2009 ·Lung Cancer ·Mirjam C. Boelens, Klaas Kok, Pieter van der Vlies, Gerben van der Vries, Hannie Sietsma, Wim Timens, Dirkje S. Postma, Harry J.M. Groen, Anke van den Berg	54
8	Current smoking‐specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer 2009 ·The Journal of Pathology ·Mirjam C. Boelens, Anke van den Berg, Rudolf S.N. Fehrmann, Marie Geerlings, Wouter K. de Jong, Gerard J. te Meerman, Hannie Sietsma, Wim Timens, Dirkje S. Postma, Harry J.M. Groen	51
9	Gangliosides do not affect ABC transporter function in human neuroblastoma cells 2006 ·Journal of Lipid Research ·(unknown), Karin Klappe, Willem A. Kamps, Hannie Sietsma, Jan Willem Kok	11
10	PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy 2006 ·Molecular Cancer Therapeutics ·(unknown), Karin Klappe, S. Jacobs, Bart‐Jan Kroesen, Willem A. Kamps, Hannie Sietsma, Jan Willem Kok	37
11	MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells 2004 ·International Journal of Cancer ·Karin Klappe, John W. J. Hinrichs, Bart‐Jan Kroesen, Hannie Sietsma, Jan Willem Kok	50
12	Sphingolipid Metabolism Enzymes as Targets for Anti-Cancer Therapy 2004 ·Current Drug Targets ·Jan Kok, Hannie Sietsma	34
13	BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the Proteasome 2003 ·Journal of Biological Chemistry ·Bart‐Jan Kroesen, S. Jacobs, Benjamin J. Pettus, Hannie Sietsma, Jan Kok, Yusuf A. Hannun, Lou F. M. H. de Leij	96
14	Differential expression of sphingolipids in P‐glycoprotein or multidrug resistance‐related protein 1 expressing human neuroblastoma cell lines 2003 ·FEBS Letters ·(unknown), (unknown), Willem A. Kamps, Hannie Sietsma, Jan Kok	18
15	Sphingolipids in Neuroblastoma: Their Role in Drug Resistance Mechanisms 2002 ·Neurochemical Research ·Hannie Sietsma, (unknown), Willem A. Kamps, Jan Kok	22
16	The Involvement of Sphingolipids in Multidrug Resistance 2001 ·The Journal of Membrane Biology ·Hannie Sietsma, Robert Jan Veldman, Jan Kok	68
17	Induction of Apoptosis through B-cell Receptor Cross-linking Occurs via de Novo Generated C16-Ceramide and Involves Mitochondria 2001 ·Journal of Biological Chemistry ·Bart‐Jan Kroesen, Benjamin J. Pettus, Chiara Luberto, Mark Busman, Hannie Sietsma, Lou de Leij, Yusuf A. Hannun	147
18	Inhibition of P-Glycoprotein Activity and Chemosensitization of Multidrug-Resistant Ovarian Carcinoma 2780AD Cells by Hexanoylglucosylceramide 1999 ·Biochemical and Biophysical Research Communications ·Robert Jan Veldman, Hannie Sietsma, Karin Klappe, Dick Hoekstra, Jan Kok	20
19	Leukemia-induced bone marrow depression: Effects of gangliosides on erythroid cell production 1999 ·International Journal of Cancer ·Hannie Sietsma, Willem A. Kamps, Bert Dontje, (unknown), Jan Kok, Edo Vellenga, W Nijhof	9
20	Inhibition of hemopoiesis in vitro by neuroblastoma-derived gangliosides. 1998 ·PubMed ·Hannie Sietsma, W Nijhof, Bert Dontje, Edo Vellenga, Willem A. Kamps, Jan Willem Kok	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact